| A randomized comparison of ginger and dimenhydrinate in the treatment of nausea and vomiting in pregnancy 2007 · Group A (ginger) · Pregnant women with nausea and vomiting in pregnancy; ages and sex beyond pregnancy not reported | 1 g | 7 days | 85 |
| The efficacy of ginger in prevention of postoperative nausea and vomiting after major gynecologic surgery 2006 · group A · Patients undergoing major gynecologic surgery; age and sex details not reported | 500 mg | 1 day | 60 |
| Ginger for prevention of antiretroviral-induced nausea and vomiting: a randomized clinical trial 2014 · ginger group · HIV-positive patients receiving antiretroviral therapy | 1 g | 2 weeks | 51 |
| The efficacy of ginger in prevention of post-operative nausea and vomiting after outpatient gynecological laparoscopy 2003 · group A · Women undergoing outpatient gynecological laparoscopy; age not reported | 500 mg | 1 day | 40 |
| Effect of ginger and P6 acupressure on chemotherapy-induced nausea and vomiting: a randomized controlled study 2024 · Ginger group · Adults aged 18 years or older with cancer who had experienced chemotherapy-induced nausea and vomiting and were receiving oxaliplatin-containing chemotherapy | 500 mg | — | 40 |
| Ginger for nausea and vomiting in pregnancy: randomized, double-masked, placebo-controlled trial 2001 · ginger group · Pregnant women at or before 17 weeks’ gestation with nausea and vomiting of pregnancy | 1 g | 4 days | 35 |
| Comparing ginger and vitamin B6 for the treatment of nausea and vomiting in pregnancy: a randomised controlled trial 2009 · ginger group · Pregnant women at or before 17 weeks’ gestation with nausea | 1 g | 4 days | 35 |
| Effectiveness of ginger for prevention of nausea and vomiting after gynecological laparoscopy 2006 · Group A · Women undergoing gynecological laparoscopy for non-cancer conditions; age not stated | 500 mg | 1 day | 30 |
| Ginger for Prevention of Antituberculosis-induced Gastrointestinal Adverse Reactions Including Hepatotoxicity: A Randomized Pilot Clinical Trial 2016 · ginger group · Patients with tuberculosis receiving antituberculosis drugs | 500 mg | 4 weeks | 30 |
| The Effect of Ginger on Breast Milk Volume in the Early Postpartum Period: A Randomized, Double-Blind Controlled Trial 2016 · ginger group · Breastfeeding women who delivered a term baby, in the early postpartum period | 1 g | 7 days | 30 |
| A comparison between the effects of ginger, pyridoxine (vitamin B6) and placebo for the treatment of the first trimester nausea and vomiting of pregnancy (NVP) 2018 · Ginger group · Pregnant women at 6–16 weeks of pregnancy with mild to moderate nausea and vomiting of pregnancy | 1 g | 4 days | 28 |
| Ginger treatment of hyperemesis gravidarum 1991 · Ginger · Pregnant women with hyperemesis gravidarum | 1 g | 4 days | 27 |
| Ginger syrup as an antiemetic in early pregnancy 2002 · ginger group · Women in the first trimester of pregnancy experiencing nausea and vomiting | 1 g | 2 weeks | 13 |
| The effects of Zintona EC (a ginger extract) on symptomatic gonarthritis 2003 · ginger extract group · Adults aged 42–85 with symptomatic gonarthritis | 1 g | 90 days | — |
| Effect of a ginger extract on pregnancy-induced nausea: a randomised controlled trial 2003 · ginger extract group · pregnant women under 20 weeks with daily morning sickness for at least a week and no relief from dietary changes | 500 mg | 4 days | — |
| Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients 2012 · 0.5g daily ginger dose · Adults with cancer who had experienced nausea during a previous chemotherapy cycle and were scheduled for further chemotherapy | 500 mg | 6 days | — |
| Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients 2012 · 1.0g daily ginger dose · Adults with cancer who had experienced nausea during a previous chemotherapy cycle and were scheduled for further chemotherapy | 1 g | 6 days | — |
| The effect of mefenamic acid and ginger on pain relief in primary dysmenorrhea: a randomized clinical trial 2015 · ginger group · Female students with moderate to severe primary dysmenorrhea | 1 g | — | — |
| Effect of Ginger and Chamomile on Nausea and Vomiting Caused by Chemotherapy in Iranian Women with Breast Cancer 2016 · ginger group · Women with breast cancer undergoing chemotherapy | 1 g | 10 days | — |
| Effect of Ginger and Novafen on menstrual pain: A cross-over trial 2018 · Ginger · Single female students aged 18–26 with primary menstrual pain | 800 mg | — | — |
| The effect of frankincense (Boswellia serrata, oleoresin) and ginger (Zingiber officinale, rhizoma) on heavy menstrual bleeding: A randomized, placebo-controlled, clinical trial 2019 · ginger group · Women of reproductive age with heavy menstrual bleeding | 900 mg | 2 weeks | — |
| A phase II randomized double-blind placebo-controlled study of 6-gingerol as an anti-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy 2017 · 6-gingerol · Patients with solid tumors receiving moderately to highly emetogenic adjuvant chemotherapy; age and sex not specified | 20 mg | 12 weeks | 42 |
| A randomized, double-blind, placebo-controlled trial on the efficacy of ginger in the prevention of abdominal distention in post cesarean section patients 2018 · ginger group · Women aged 18–40 within 24 hours postpartum after cesarean section | 1.5 g | 3 days | 89 |
| A randomized comparison of ginger and vitamin B6 in the treatment of nausea and vomiting of pregnancy 2003 · ginger group · Pregnant women at or before 16 weeks of gestation with nausea and vomiting of pregnancy | 1.5 g | 3 days | 64 |
| Effect of Zingiber officinale R. rhizomes (ginger) on pain relief in primary dysmenorrhea: a placebo randomized trial 2012 · Ginger group, treatment protocol 1 · Female students aged 18 and over with moderate to severe primary dysmenorrhea | 1.5 g | 5 days | 59 |
| Effect of Zingiber officinale R. rhizomes (ginger) on pain relief in primary dysmenorrhea: a placebo randomized trial 2012 · Ginger group, treatment protocol 2 · Female students aged 18 and over with moderate to severe primary dysmenorrhea | 1.5 g | 3 days | 59 |
| Effectiveness and safety of steamed ginger extract on mild osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial 2024 · GGE03 group · People with mild knee osteoarthritis | 480 mg | 12 weeks | 50 |
| Ginger extract versus Loratadine in the treatment of allergic rhinitis: a randomized controlled trial 2020 · Ginger extract · Adults aged 18–70 with doctor-diagnosed moderate allergic rhinitis | 250 mg | 6 weeks | 40 |
| Efficacy and safety of steamed ginger extract for gastric health: a randomized, double-blind, placebo-controlled multi-center clinical trial 2025 · GGE03 group · Adults with mild to moderate functional dyspepsia | 480 mg | 12 weeks | 40 |
| Efficacy and Safety of Steamed Ginger Extract for Body Weight and Body Fat Reduction in Overweight Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial 2026 · GGE03 group · Men and women aged 18–60 years with overweight (BMI 25.00–29.99 kg/m²) | 480 mg | 12 weeks | 40 |
| The effect of ginger (Zingiber officinale) supplementation on clinical, biochemical, and anthropometric parameters in patients with multiple sclerosis: a double-blind randomized controlled trial 2023 · treatment group · Patients with relapsing-remitting multiple sclerosis; age and sex not specified | 1.5 g | 12 weeks | 26 |
| The effects of ginger supplementation on common gastrointestinal symptoms in patients with relapsing-remitting multiple sclerosis: a double-blind randomized placebo-controlled trial 2023 · ginger group · Men and non-menopausal women aged 18–50 with relapsing-remitting multiple sclerosis | 1.5 g | 12 weeks | 26 |
| Ashwagandha (Withania somnifera) and Shunthi (Zingiber officinale) in mild and moderate COVID-19: An open-label randomized controlled exploratory trial 2023 · Ayurveda group (AG) · People with mild or moderate COVID-19; age and sex not reported | 1 g | 15 days | 25 |
| Effects of ginger on gastric emptying and motility in healthy humans 2008 · ginger · healthy volunteers; age and sex not reported | 1.2 g | 1 day | 24 |
| A Randomized Double-Blind Trial of Ginger Root for Reducing Muscle Soreness and Improving Physical Performance Recovery Among Experienced Recreational Distance Runners 2020 · ginger root · Experienced recreational distance runners; 10 women and 22 men; age and health condition not specified | 1.43 g | 5 days | 16 |
| Effect of ginger on gastric motility and symptoms of functional dyspepsia 2011 · ginger · 11 patients with functional dyspepsia | 1.2 g | 1 day | 11 |
| A randomized controlled trial of ginger to treat nausea and vomiting in pregnancy 2004 · ginger group · Pregnant women less than 16 weeks pregnant | 1.05 g | 3 weeks | — |
| Comparison of the effectiveness of ginger and vitamin B6 for treatment of nausea and vomiting in early pregnancy: a randomized double-blind controlled trial 2007 · ginger · Pregnant women at gestational age 16 weeks or less with nausea and vomiting | 1.95 g | 4 days | — |
| Ginger (Zingiber officinale) reduces muscle pain caused by eccentric exercise 2010 · raw ginger group (study 1) · Volunteers who performed eccentric elbow-flexor exercise to induce muscle pain | 2 g | 11 days | — |
| Ginger (Zingiber officinale) reduces muscle pain caused by eccentric exercise 2010 · heat-treated ginger group (study 2) · Volunteers who performed eccentric elbow-flexor exercise to induce muscle pain | 2 g | 11 days | — |
| Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients 2012 · 1.5g daily ginger dose · Adults with cancer who had experienced nausea during a previous chemotherapy cycle and were scheduled for further chemotherapy | 1.5 g | 6 days | — |
| Effect of ginger on acute and delayed chemotherapy-induced nausea and vomiting: a pilot, randomized, open-label clinical trial 2012 · ginger group · Women with advanced breast cancer receiving TEC chemotherapy | 1.5 g | 4 days | — |
| Effect of Zingiber officinale Supplementation on Obesity Management with Respect to the Uncoupling Protein 1 -3826A>G and ß3-adrenergic Receptor Trp64Arg Polymorphism 2015 · ginger · Women aged 18–45 years with obesity | 2 g | 12 weeks | — |
| The Effect of a Standardized Ginger Extract on Chemotherapy-Induced Nausea-Related Quality of Life in Patients Undergoing Moderately or Highly Emetogenic Chemotherapy: A Double Blind, Randomized, Placebo Controlled Trial 2017 · ginger group · Adults aged 18 or older who were chemotherapy-naïve and scheduled to receive moderately or highly emetogenic chemotherapy | 1.2 g | 15 days | — |
| The effect of ginger supplementation on some immunity and inflammation intermediate genes expression in patients with active Rheumatoid Arthritis 2019 · ginger group · Patients with active rheumatoid arthritis; age and sex not stated | 1.5 g | 12 weeks | — |
| Effects of ginger adjunct to the standard prophylaxis on reducing carboplatin and paclitaxel-induced nausea vomiting: a randomized controlled study 2020 · ginger · Patients with gynecologic malignancies receiving carboplatin-paclitaxel chemotherapy | 2 g | — | — |
| A Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Comparative Clinical Study to Evaluate the Efficacy and Safety of OLNP-06 versus Placebo in Subjects with Functional Dyspepsia 2022 · OLNP-06 group · Adults aged 18–55 with functional dyspepsia meeting Rome III criteria | 400 mg | — | — |
| The Effects of Ginger (Zingiber Officinale Roscoe) on Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blinded Placebo-Controlled Clinical Trial 2024 · ginger group · Patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease; age and sex not specified | 2 g | 90 days | — |
| Effect of a Standardized Ginger Root Powder Regimen on Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial 2024 · ginger · Chemotherapy-naïve adults scheduled to receive moderately to highly emetogenic chemotherapy | 84 mg | 5 days | 52 |
| Effects of Ginger Supplementation on Markers of Inflammation and Functional Capacity in Individuals with Mild to Moderate Joint Pain 2025 · ginger group · Adults aged 40–75, male and female, with mild to moderate joint and muscle pain and elevated inflammatory markers and/or a history of physician-diagnosed osteoarthritis | 125 mg | 58 days | 15 |
| The effects of combination of Zingiber officinale and Echinacea on alleviation of clinical symptoms and hospitalization rate of suspected COVID-19 outpatients: a randomized controlled trial 2021 · intervention group · suspected COVID-19 outpatients; age and sex not reported | 1.5 g | 7 days | 50 |
| The Effect of Dietary Supplements Containing Green Tea, Capsaicin and Ginger Extracts on Weight Loss and Metabolic Profiles in Overweight Women: A Randomized Double-Blind Placebo-Controlled Clinical Trial 2017 · Group A · Overweight women | 200 mg | 8 weeks | 25 |
| Influence of a specific ginger combination on gastropathy conditions in patients with osteoarthritis of the knee or hip 2012 · ginger group · Adults with confirmed knee or hip osteoarthritis; ages not reported; 17 women and 4 men | 340 mg | 4 weeks | 21 |
| The effect of ginger powder supplementation on insulin resistance and glycemic indices in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial 2014 · ginger (GG) · people with type 2 diabetes; age and sex not specified | 3 g | 8 weeks | — |
| A commercialized dietary supplement alleviates joint pain in community adults: a double-blind, placebo-controlled community trial 2013 · Instaflex · Men and women aged 50–75 with self-reported joint pain lasting more than 3 months | 50 mg | 8 weeks | 49 |
| Effects of Aphrodite (an Herbal Compound) on SSRI-Induced Sexual Dysfunctions and Depression in Females with Major Depressive Disorder: Findings from a Randomized Clinical Trial 2023 · Aphrodite · Females aged 18–50 with major depressive disorder and SSRI-induced sexual dysfunction, taking sertraline | 12.3 mg | 8 weeks | 22 |
| Hemp Seed Oil in Association with β-Caryophyllene, Myrcene and Ginger Extract as a Nutraceutical Integration in Knee Osteoarthritis: A Double-Blind Prospective Case-Control Study 2023 · treatment group · Adults aged 45–70 with a clinical diagnosis of knee osteoarthritis, radiographic grade II–III, and knee pain of at least 4 on the Numeric Rating Scale | 132 mg | 45 days | 19 |
| Effect of ginger on lower esophageal sphincter pressure 2010 · Ginger · Healthy young men | 1 g | 1 day | 14 |
| Effects of ginger supplementation on cell-cycle biomarkers in the normal-appearing colonic mucosa of patients at increased risk for colorectal cancer: results from a pilot, randomized, and controlled trial 2013 · ginger extract · Adults aged 18 years or older at increased risk for colorectal cancer, male and female | 500 mg | 4 weeks | 10 |
| Effects of ginger on serum glucose, advanced glycation end products, and inflammation in peritoneal dialysis patients 2015 · ginger group · Patients on peritoneal dialysis | 1 g | 10 weeks | — |
| Effects of Ginger on Serum Lipids and Lipoproteins in Peritoneal Dialysis Patients: A Randomized Controlled Trial 2016 · ginger group · Peritoneal dialysis patients; age and sex not specified | 1 g | 10 weeks | — |
| Effect of Ginger Supplementation on Proinflammatory Cytokines in Older Patients with Osteoarthritis: Outcomes of a Randomized Controlled Clinical Trial 2016 · ginger group (GG) · Older patients with knee osteoarthritis | 500 mg | 90 days | — |
| Effectiveness of ginger in reducing metabolic levels in people with diabetes: a randomized clinical trial 2020 · Experimental Group (EG) · Adults aged 20–80 with type 2 diabetes for at least two years, taking oral antidiabetic drugs and with baseline HbA1c of 6.0%–10.0% | 1.2 g | 90 days | 47 |
| A Triple-blind randomized controlled trial on the effects of turmeric versus ginger on inflammatory biomarkers in patients with COVID-19 2025 · Group G (ginger group) · Adults aged 18 years or older with mild COVID-19 | 1.5 g | 5 days | 44 |
| Effect of ginger on the blood glucose level of women with gestational diabetes mellitus (GDM) with impaired glucose tolerance test (GTT): a randomized double-blind placebo-controlled trial 2020 · ginger group · Pregnant women with gestational diabetes mellitus and impaired glucose tolerance test at 24–28 weeks of pregnancy | 1.5 g | 6 weeks | 41 |
| Effect of ginger supplementation on the fecal microbiome in subjects with prior colorectal adenoma 2024 · ginger · Adults aged 50–75 with a colorectal adenoma diagnosed within the previous five years | 1.5 g | 6 weeks | 33 |
| Effect of Ginger Root Powder on Gastrointestinal Bacteria Composition, Gastrointestinal Symptoms, Mental Health, Fatigue, and Quality of Life: A Double-Blind Placebo-Controlled Trial 2023 · ginger · Healthy adults aged 18 to 30 years | 1.2 g | 2 weeks | 29 |
| The effect of zingiber officinale on prooxidant-antioxidant balance and glycemic control in diabetic patients with ESRD undergoing hemodialysis: a double-blind randomized control trial 2023 · ginger group · Adults aged 31–77 with type 2 diabetes and end-stage renal disease receiving hemodialysis | 2 g | 8 weeks | 22 |
| Effect of ginger root on cyclooxygenase-1 and 15-hydroxyprostaglandin dehydrogenase expression in colonic mucosa of humans at normal and increased risk for colorectal cancer 2013 · ginger extract, normal-risk study · Adults aged 18 years or older at normal risk for colorectal cancer, in generally good health | 2 g | 4 weeks | 16 |
| Effect of ginger root on cyclooxygenase-1 and 15-hydroxyprostaglandin dehydrogenase expression in colonic mucosa of humans at normal and increased risk for colorectal cancer 2013 · ginger extract, increased-risk study · Adults aged 18 years or older at increased risk for colorectal cancer, in generally good health | 2 g | 4 weeks | 11 |
| Ginger consumption enhances the thermic effect of food and promotes feelings of satiety without affecting metabolic and hormonal parameters in overweight men: a pilot study 2012 · ginger test day · Men aged 19–50 years with BMI 25–29.9 kg/m²; overweight and without stated chronic health conditions | 2 g | 1 day | 10 |
| Pilot clinical study of the effects of ginger root extract on eicosanoids in colonic mucosa of subjects at increased risk for colorectal cancer 2015 · ginger group · Adults aged 18 years or older at increased risk for colorectal cancer, due to family history, a previous adenomatous polyp, or resected early-stage colon cancer | 2 g | 4 weeks | 10 |
| Effects of ginger (Zingiber officinale) on plasma glucose level, HbA1c and insulin sensitivity in type 2 diabetic patients 2013 · ginger group · Patients with type 2 diabetes; age and sex not specified | 2 g | 60 days | — |
| The effect of ginger consumption on glycemic status, lipid profile and some inflammatory markers in patients with type 2 diabetes mellitus 2014 · ginger group · Patients with type 2 diabetes mellitus; age and sex not specified | 1.6 g | 12 weeks | — |
| Changes of serum adipocytokines and body weight following Zingiber officinale supplementation in obese women: a RCT 2016 · ginger group · Obese women aged 18–45 years | 2 g | 12 weeks | — |
| Zingiber officinale and oxidative stress in patients with ulcerative colitis: A randomized, placebo-controlled, clinical trial 2019 · ginger · Patients with active mild to moderate ulcerative colitis | 2 g | 12 weeks | — |
| Beneficial Effects of Ginger Extract on Eye Fatigue and Shoulder Stiffness: A Randomized, Double-Blind, and Placebo-Controlled Parallel Study 2024 · ginger group · Healthy adults aged 20–75 with eye fatigue and shoulder stiffness | 100 mg | 8 weeks | 51 |
| Investigation of the effect of ginger on the lipid levels. A double blind controlled clinical trial 2008 · treatment group · Patients with hyperlipidemia; age and sex not specified | 3 g | 45 days | 45 |
| The Effect of Therapeutic Doses of Culinary Spices in Metabolic Syndrome: A Randomized Controlled Trial 2024 · ginger group · Adults aged 18–50 at risk of metabolic syndrome or with metabolic syndrome; men and women | 3 g | 12 weeks | 30 |
| Change in adiponectin and oxidative stress after modifiable lifestyle interventions in breast cancer cases 2013 · ginger supplement · Obese women with breast cancer; mean age 48 ± 5.4 years | 3 g | 6 weeks | — |
| Change in adiponectin and oxidative stress after modifiable lifestyle interventions in breast cancer cases 2013 · water-based exercise+ginger supplement · Obese women with breast cancer; mean age 48 ± 5.4 years | 3 g | 6 weeks | — |
| The effect of ginger (Zingiber officinale) on glycemic markers in patients with type 2 diabetes 2015 · Ginger group · Adults aged 20–60 with type 2 diabetes who did not receive insulin | 3 g | 90 days | — |
| Anti-inflammatory and antioxidant effect of ginger in tuberculosis 2016 · intervention group · Pulmonary tuberculosis patients receiving standard antitubercular treatment; age and sex not reported | 3 g | 30 days | — |
| [Effect of Sini decoction on function of hypothalamic-pituitary-adrenal axis in patients with sepsis] 2014 · Chinese herb group · Adults with sepsis | 15 g | 7 days | 20 |